Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function

Leukemia Research

Volumn 37, Issue 7, 2013, Pages 822-828

  Brady, Michael T ^a   Miller, Austin ^a   Sait, Sheila N ^a   Ford, Laurie A ^a   Minderman, Hans ^a   Wang, Eunice S ^a   Lee, Kelvin P ^a   Baumann, Heinz ^a   Wetzler, Meir ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid leukemia; Dendritic cells; STAT3

Indexed keywords

4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; ARSENIC TRIOXIDE; INTERLEUKIN 12P40; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; SHORT HAIRPIN RNA; STAT3 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AMINOSALICYLIC ACIDS; ANTIGEN-PRESENTING CELLS; ANTINEOPLASTIC AGENTS; ARSENICALS; BENZENESULFONATES; BLAST CRISIS; BLOTTING, WESTERN; DENDRITIC CELLS; DOWN-REGULATION; ENDOCYTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE ACTIVATION; OXIDES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 84878478231     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.04.002     Document Type: Article

References (15)

1. Cheng F., Wang H.W., Cuenca A., Huang M., Ghansah T., Brayer J., et al. A critical role for Stat3 signaling in immune tolerance. Immunity 2003, 19:425-436.
2. Wang T., Niu G., Kortylewski M., Burdelya L., Shain K., Zhang S., et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 2004, 10:48-54.
3. Nefedova Y., Huang M., Kusmartsev S., Bhattacharya R., Cheng P., Salup R., et al. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol 2004, 172:464-474.
4. Kortylewski M., Yu H. Role of Stat3 in suppressing anti-tumor immunity. Curr Opin Immunol 2008, 20:228-233.
5. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev 2009, 9:798-809.
6. Nefedova Y., Cheng P., Gilkes D., Blaskovich M., Beg A.A., Sebti S.M., et al. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J Immunol 2005, 175:4338-4346.
7. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379:645-648.
8. Wetzler M., Brady M.T., Tracy E., Li Z.R., Donohue K.A., O'Loughlin K.L., et al. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation. Clin Cancer Res 2006, 12:6817-6825.
9. Blaskovich M.A., Sun J., Cantor A., Turkson J., Jove R., Sebti S.M. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003, 63:1270-1279.
10. Siddiquee K., Zhang S., Guida W.C., Blaskovich M.A., Greedy B., Lawrence H.R., et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007, 104:7391-7396.
11. Lee J., Sait S.N., Wetzler M. Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts. Int Immunol 2004, 16:1377-1389.
12. Wang L.H., Kirken R.A., Erwin R.A., Yu C.R., Farrar W.L. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response. J Immunol 1999, 162:3897-3904.
13. Janeway C.A., Walport T.P., Shlomchik M.M. Immunobiology 2005, Garland Science, NewYork, NY. 6th ed.
14. Hoentjen F., Sartor R.B., Ozaki M., Jobin C. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 2005, 105:689-696.
15. Houtenbos I., Westers T.M., Hess C.J., Waisfisz Q., Ossenkoppele G.J., van de Loosdrecht A.A. Flt-3 internal tandem duplication hampers differentiation of AML blasts towards leukemic dendritic cells. Leukemia 2006, 20:1892-1895.